Scholarly Index
Tamara L. Lotan
Johns Hopkins University; 15,995 total citations; 381 total publications; best world rank #35
Johns Hopkins University
15,995Total citations
381Total publications
64H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Prostate Cancer Treatment and Research | Lifetime | 304 | US 176 | 99.06 |
| Prostate Cancer Diagnosis and Treatment | Lifetime | 411 | US 207 | 98.71 |
| Urologic and reproductive health conditions | Lifetime | 343 | US 184 | 97.89 |
| Cancer, Lipids, and Metabolism | Lifetime | 788 | US 368 | 97.27 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 563 | US 308 | 95.90 |
| PARP inhibition in cancer therapy | Lifetime | 526 | US 244 | 94.36 |
| Tuberous Sclerosis Complex Research | Lifetime | 646 | US 305 | 81.79 |
| Prostate Cancer Treatment and Research | 2021-2025 | 72 | US 31 | 99.18 |
| Prostate Cancer Diagnosis and Treatment | 2021-2025 | 274 | US 83 | 96.93 |
| PARP inhibition in cancer therapy | 2021-2025 | 165 | US 63 | 94.46 |
| Renal cell carcinoma treatment | 2021-2025 | 410 | US 152 | 93.84 |
| Tuberous Sclerosis Complex Research | 2021-2025 | 35 | US 16 | 90.29 |
| Renal and related cancers | 2021-2025 | 432 | US 175 | 88.84 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 645 | US 128 | 87.19 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 649 | US 227 | 66.19 |